Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population

Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further resul...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 263; pp. 205 - 210
Main Authors Rong, Dan, Liu, Jie, Jia, Xin, AL-Nafisee, Daniah, Jia, Senhao, Sun, Guoyi, Li, Yue, Lu, Weihang, Li, Haifeng, Zhang, Hongpeng, Ma, Xiaohui, Xiong, Jiang, Liu, Xiaoping, Khalil, Raouf A., Guo, Wei
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.08.2017
Subjects
Online AccessGet full text
ISSN0021-9150
1879-1484
1879-1484
DOI10.1016/j.atherosclerosis.2017.05.006

Cover

Abstract Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results. 240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease. The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors. In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship. •Participants with hyperhomocysteinaemia (HHcy) suffer a higher risk of peripheral arterial disease (PAD).•HHcy is an independent risk factor for PAD in a Chinese Han population.•This is the first case-control study to investigate the relationship between HHcy and PAD in Chinese mainland.
AbstractList Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results. 240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease. The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors. In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.
Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results. 240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease. The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors. In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship. •Participants with hyperhomocysteinaemia (HHcy) suffer a higher risk of peripheral arterial disease (PAD).•HHcy is an independent risk factor for PAD in a Chinese Han population.•This is the first case-control study to investigate the relationship between HHcy and PAD in Chinese mainland.
Abstract Background and aims Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results. Methods 240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease. Results The multivariate logistic analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independent of classical vascular risk factors. Conclusions In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.
Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results.BACKGROUND AND AIMSHyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial disease (PAD) is still controversial. There is a lack of research on this topic in the Chinese population. This study aims to provide further results.240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease.METHODS240 PAD patients and 240 control subjects were evaluated for both serum total homocysteine levels and ankle brachial indexes (ABIs). Multivariable logistic regression models were used to estimate the association between HHcy and the risk of developing PAD. Interaction and stratified analyses were conducted according to age, sex, smoking status, drinking status, and histories of chronic disease.The multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors.RESULTSThe multivariate logistic regression analyses revealed that the risk of PAD was significantly associated with serum homocysteine levels. The interaction analysis showed no interactive role in the association between HHcy and PAD, indicating that homocysteine was associated with PAD independently of classical vascular risk factors.In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.CONCLUSIONSIn conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.
Author Jia, Xin
Khalil, Raouf A.
Zhang, Hongpeng
Liu, Jie
Guo, Wei
Sun, Guoyi
Ma, Xiaohui
AL-Nafisee, Daniah
Xiong, Jiang
Jia, Senhao
Li, Yue
Li, Haifeng
Rong, Dan
Lu, Weihang
Liu, Xiaoping
AuthorAffiliation a Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
e Department of Vascular and Endovascular Surgery, Shanxian Dongda Hospital, Heze, Shandong, China
b Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
c School of Medicine, The Royal College of Surgeons, Dublin, Ireland
d Department of Cardiovascular Surgery, Chinese PLA Air Force General Hospital, Beijing, China
AuthorAffiliation_xml – name: b Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
– name: a Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– name: e Department of Vascular and Endovascular Surgery, Shanxian Dongda Hospital, Heze, Shandong, China
– name: c School of Medicine, The Royal College of Surgeons, Dublin, Ireland
– name: d Department of Cardiovascular Surgery, Chinese PLA Air Force General Hospital, Beijing, China
Author_xml – sequence: 1
  givenname: Dan
  surname: Rong
  fullname: Rong, Dan
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 2
  givenname: Jie
  surname: Liu
  fullname: Liu, Jie
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 3
  givenname: Xin
  surname: Jia
  fullname: Jia, Xin
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 4
  givenname: Daniah
  surname: AL-Nafisee
  fullname: AL-Nafisee, Daniah
  organization: School of Medicine, The Royal College of Surgeons, Dublin, Ireland
– sequence: 5
  givenname: Senhao
  surname: Jia
  fullname: Jia, Senhao
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 6
  givenname: Guoyi
  surname: Sun
  fullname: Sun, Guoyi
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 7
  givenname: Yue
  surname: Li
  fullname: Li, Yue
  organization: Department of Cardiovascular Surgery, Chinese PLA Air Force General Hospital, Beijing, China
– sequence: 8
  givenname: Weihang
  surname: Lu
  fullname: Lu, Weihang
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 9
  givenname: Haifeng
  surname: Li
  fullname: Li, Haifeng
  organization: Department of Vascular and Endovascular Surgery, Shanxian Dongda Hospital, Heze, Shandong, China
– sequence: 10
  givenname: Hongpeng
  surname: Zhang
  fullname: Zhang, Hongpeng
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 11
  givenname: Xiaohui
  surname: Ma
  fullname: Ma, Xiaohui
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 12
  givenname: Jiang
  surname: Xiong
  fullname: Xiong, Jiang
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 13
  givenname: Xiaoping
  surname: Liu
  fullname: Liu, Xiaoping
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
– sequence: 14
  givenname: Raouf A.
  surname: Khalil
  fullname: Khalil, Raouf A.
  organization: Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
– sequence: 15
  givenname: Wei
  surname: Guo
  fullname: Guo, Wei
  email: guoweiplagh@sina.com
  organization: Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28651188$$D View this record in MEDLINE/PubMed
BookMark eNqVkk1v1DAQhi1URLeFv4ByQeKywU6cxDlQCa1KF6kSB-BsOc6EnW1iBzuptP-eCdsiWAmpHPwlzzwzfl9fsDPnHTD2RvBUcFG-26dm2kHw0fbLjDHNuKhSXqScl8_YSqiqXgup5BlbcZ6JdS0Kfs4uYtxzzmUl1At2nqmyEEKpFfPbwwhh5wdvD3ECdAYGNAnGxLgEXQsj0OSmJGC8SzpjJx-SjgZl4UiNmD4xYaIDbVqMYCJQXmKSzQ4d0GFLoNGPc28m9O4le96ZPsKrh_WSfft4_XWzXd9-vvm0-XC7tqUop3Vl2rqVjbClrGQrlK2aRsqmtrnkEkqojelU3tWNqekuLzkHk3cqgzaXIm9lfsmujtxxbgZoLT2BWtVjwMGEg_YG9d83Dnf6u7_XRVFUpSoI8PYBEPyPGeKkB4wW-t448HPUohaSZFSZotDXf9b6XeRRZQrYHAMsORYDdNri9EsOKo29Flwv3uq9PvFWL95qXmjylijvTyiPhZ6af3PMB9L9HiHoaBGchRYD2Em3Hp9Mujoh2R4dWtPfwQHi3s_Bkbla6Jhprr8s_3D5hqLKuaiLRZDrfwP-o5GfqGP9Cg
CitedBy_id crossref_primary_10_1016_j_avsg_2020_11_043
crossref_primary_10_1080_02713683_2021_1894581
crossref_primary_10_1016_j_omtn_2021_10_031
crossref_primary_10_1097_MD_0000000000009801
crossref_primary_10_1186_s40001_022_00870_1
crossref_primary_10_3389_fphys_2018_01000
crossref_primary_10_3892_mmr_2019_10804
crossref_primary_10_1155_2020_4378505
crossref_primary_10_1080_07853890_2025_2457527
crossref_primary_10_1186_s12872_023_03586_0
crossref_primary_10_1016_j_jhin_2018_06_017
crossref_primary_10_1080_15384101_2018_1480207
crossref_primary_10_12677_acm_2024_1441346
crossref_primary_10_1155_2020_4691026
crossref_primary_10_1016_j_amjcard_2024_03_002
crossref_primary_10_2147_DMSO_S309242
crossref_primary_10_1155_2020_6960497
crossref_primary_10_2478_jtim_2021_0035
crossref_primary_10_3389_fcvm_2022_1109445
crossref_primary_10_1016_j_avsg_2019_06_026
crossref_primary_10_2147_DMSO_S267122
crossref_primary_10_1111_jch_14766
crossref_primary_10_1002_ptr_7519
Cites_doi 10.1056/NEJMoa060900
10.1016/j.freeradbiomed.2013.07.041
10.1016/S0140-6736(13)61249-0
10.1016/0735-1097(95)00508-0
10.1017/S0029665108007076
10.1016/S0950-821X(05)80255-5
10.1001/jama.2015.2274
10.1016/j.jclinepi.2006.01.014
10.1016/j.ab.2014.08.013
10.1056/NEJMcp1507631
10.1053/meta.2001.23286
10.1007/s00392-012-0471-z
10.1001/archinternmed.2010.348
10.1016/j.jvs.2008.10.004
10.1001/jama.285.19.2481
10.1016/j.atherosclerosis.2014.04.010
10.1097/00008571-200210000-00003
10.1093/eurheartj/ehu080
10.1016/0021-9150(90)90058-Q
10.1161/CIR.0b013e318276fbcb
10.1016/j.ejvs.2009.05.007
10.1056/NEJM199104253241701
10.1056/NEJM199804093381507
10.1586/17512433.2015.1010516
10.1161/CIRCULATIONAHA.105.608679
10.1161/CIRCULATIONAHA.107.719369
10.1038/srep17966
10.1016/0741-5214(91)90020-U
10.1016/0002-9343(94)90149-X
10.1001/jama.295.2.180
10.1007/s100169900037
10.1093/ije/25.2.282
10.1038/nm0496-386
10.1001/jama.1995.03530130055028
ContentType Journal Article
Copyright 2017 Elsevier B.V.
Copyright © 2017 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2017 Elsevier B.V.
– notice: Copyright © 2017 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.atherosclerosis.2017.05.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1484
EndPage 210
ExternalDocumentID PMC5557685
28651188
10_1016_j_atherosclerosis_2017_05_006
S0021915017301958
1_s2_0_S0021915017301958
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R21 HL111775
– fundername: NHLBI NIH HHS
  grantid: R01 HL065998
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
Z5R
ZGI
ZXP
~G-
~KM
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
RIG
0SF
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
ACLOT
CITATION
~HD
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c616t-7ad9d4b1c6474d18c7bb44b9c3404e6e9aaf83f9ba98c73600ea3f82ed3413d43
IEDL.DBID .~1
ISSN 0021-9150
1879-1484
IngestDate Tue Sep 30 16:12:12 EDT 2025
Sat Sep 27 20:19:03 EDT 2025
Mon Jul 21 06:00:18 EDT 2025
Thu Apr 24 22:56:01 EDT 2025
Wed Oct 01 05:20:42 EDT 2025
Fri Feb 23 02:49:21 EST 2024
Sun Feb 23 10:19:10 EST 2025
Tue Aug 26 16:36:41 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords WHS
PLA
CAD
Peripheral arterial disease
ABI
Case-control study
Hyperhomocysteineamia
HDL
PAD
5-MTHF
LDL
HHcy
NHS
PHS
Homocysteine
HOPE
coronary artery disease
people's liberation army
Physicians' Health Study
Heart Outcomes Prevention Evaluation
high-density lipoprotein
5-methyltetrahydrofolate
Nurses' Health Study
Women's Health Study
ankle brachial index
low-density lipoprotein
Language English
License Copyright © 2017 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c616t-7ad9d4b1c6474d18c7bb44b9c3404e6e9aaf83f9ba98c73600ea3f82ed3413d43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/5557685
PMID 28651188
PQID 1914286828
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5557685
proquest_miscellaneous_1914286828
pubmed_primary_28651188
crossref_citationtrail_10_1016_j_atherosclerosis_2017_05_006
crossref_primary_10_1016_j_atherosclerosis_2017_05_006
elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2017_05_006
elsevier_clinicalkeyesjournals_1_s2_0_S0021915017301958
elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2017_05_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-08-01
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Atherosclerosis
PublicationTitleAlternate Atherosclerosis
PublicationYear 2017
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Kumbhani (bib5) 2014; 35
Beutner (bib21) 2012; 101
Brown (bib31) 2014; 467
Kullo, Rooke (bib1) 2016; 374
Boushey (bib13) 1995; 274
Fowkes (bib2) 2013; 382
Bertoia (bib27) 2014; 235
Khandanpour (bib17) 2009; 38
Liu (bib19) 2016; 6
Ridker, Stampfer, Rifai (bib23) 2001; 285
Mayer, Jacobsen, Robinson (bib12) 1996; 27
Welch, Loscalzo (bib9) 1998; 338
Taylor (bib25) 1991; 13
Dierkes (bib28) 2001; 50
Lonn (bib36) 2006; 354
McNulty (bib33) 2008; 67
Brattstrom (bib15) 1990; 81
Goodman (bib30) 2002; 12
McCully (bib32) 2015; 8
Aboyans (bib24) 2006; 113
Donders (bib22) 2006; 59
Bhatt (bib4) 2006; 295
McCully (bib6) 1969; 56
Pradhan (bib26) 2008; 117
Khandanpour (bib34) 2009; 49
Huo (bib35) 2015; 313
Clarke (bib14) 1991; 324
Ueland, Refsum (bib7) 1989; 114
Chauveau (bib10) 1993; 41
Cheng, Ting, Wong (bib18) 1997; 11
Aboyans (bib20) 2012; 126
Savage (bib11) 1994; 96
Stoffers (bib3) 1996; 25
McCully (bib8) 1996; 2
Bergmark (bib16) 1993; 7
Gaikwad (bib29) 2013; 65
Clarke (bib37) 2010; 170
Ridker (10.1016/j.atherosclerosis.2017.05.006_bib23) 2001; 285
Brattstrom (10.1016/j.atherosclerosis.2017.05.006_bib15) 1990; 81
Gaikwad (10.1016/j.atherosclerosis.2017.05.006_bib29) 2013; 65
Kumbhani (10.1016/j.atherosclerosis.2017.05.006_bib5) 2014; 35
Welch (10.1016/j.atherosclerosis.2017.05.006_bib9) 1998; 338
Mayer (10.1016/j.atherosclerosis.2017.05.006_bib12) 1996; 27
Chauveau (10.1016/j.atherosclerosis.2017.05.006_bib10) 1993; 41
Khandanpour (10.1016/j.atherosclerosis.2017.05.006_bib17) 2009; 38
Bhatt (10.1016/j.atherosclerosis.2017.05.006_bib4) 2006; 295
Aboyans (10.1016/j.atherosclerosis.2017.05.006_bib24) 2006; 113
Fowkes (10.1016/j.atherosclerosis.2017.05.006_bib2) 2013; 382
Clarke (10.1016/j.atherosclerosis.2017.05.006_bib14) 1991; 324
Savage (10.1016/j.atherosclerosis.2017.05.006_bib11) 1994; 96
McCully (10.1016/j.atherosclerosis.2017.05.006_bib8) 1996; 2
Bertoia (10.1016/j.atherosclerosis.2017.05.006_bib27) 2014; 235
Dierkes (10.1016/j.atherosclerosis.2017.05.006_bib28) 2001; 50
McNulty (10.1016/j.atherosclerosis.2017.05.006_bib33) 2008; 67
Donders (10.1016/j.atherosclerosis.2017.05.006_bib22) 2006; 59
Clarke (10.1016/j.atherosclerosis.2017.05.006_bib37) 2010; 170
Beutner (10.1016/j.atherosclerosis.2017.05.006_bib21) 2012; 101
Bergmark (10.1016/j.atherosclerosis.2017.05.006_bib16) 1993; 7
Aboyans (10.1016/j.atherosclerosis.2017.05.006_bib20) 2012; 126
Huo (10.1016/j.atherosclerosis.2017.05.006_bib35) 2015; 313
Ueland (10.1016/j.atherosclerosis.2017.05.006_bib7) 1989; 114
Boushey (10.1016/j.atherosclerosis.2017.05.006_bib13) 1995; 274
Pradhan (10.1016/j.atherosclerosis.2017.05.006_bib26) 2008; 117
Lonn (10.1016/j.atherosclerosis.2017.05.006_bib36) 2006; 354
McCully (10.1016/j.atherosclerosis.2017.05.006_bib6) 1969; 56
Goodman (10.1016/j.atherosclerosis.2017.05.006_bib30) 2002; 12
Liu (10.1016/j.atherosclerosis.2017.05.006_bib19) 2016; 6
Kullo (10.1016/j.atherosclerosis.2017.05.006_bib1) 2016; 374
Stoffers (10.1016/j.atherosclerosis.2017.05.006_bib3) 1996; 25
Taylor (10.1016/j.atherosclerosis.2017.05.006_bib25) 1991; 13
McCully (10.1016/j.atherosclerosis.2017.05.006_bib32) 2015; 8
Cheng (10.1016/j.atherosclerosis.2017.05.006_bib18) 1997; 11
Brown (10.1016/j.atherosclerosis.2017.05.006_bib31) 2014; 467
Khandanpour (10.1016/j.atherosclerosis.2017.05.006_bib34) 2009; 49
12360102 - Pharmacogenetics. 2002 Oct;12(7):517-28
8154512 - Am J Med. 1994 Mar;96(3):239-46
16403930 - JAMA. 2006 Jan 11;295(2):180-9
25771069 - JAMA. 2015 Apr 7;313(13):1325-35
8359294 - Eur J Vasc Surg. 1993 Jul;7(4):391-6
25172130 - Anal Biochem. 2014 Dec 15;467:14-21
9140594 - Ann Vasc Surg. 1997 May;11(3):217-23
23159553 - Circulation. 2012 Dec 11;126(24):2890-909
16980149 - J Clin Epidemiol. 2006 Oct;59(10):1087-91
23915883 - Lancet. 2013 Oct 19;382(9901):1329-40
7563456 - JAMA. 1995 Oct 4;274(13):1049-57
23928335 - Free Radic Biol Med. 2013 Dec;65:1447-54
8320950 - Kidney Int Suppl. 1993 Jun;41:S72-7
9535670 - N Engl J Med. 1998 Apr 9;338(15):1042-50
19157768 - J Vasc Surg. 2009 Mar;49(3):711-8
24819748 - Atherosclerosis. 2014 Jul;235(1):94-101
9119553 - Int J Epidemiol. 1996 Apr;25(2):282-90
22584382 - Clin Res Cardiol. 2012 Nov;101(11):875-83
19560951 - Eur J Vasc Endovasc Surg. 2009 Sep;38(3):316-22
11368701 - JAMA. 2001 May 16;285(19):2481-5
26962905 - N Engl J Med. 2016 Mar 3;374(9):861-71
8597939 - Nat Med. 1996 Apr;2(4):386-9
8606260 - J Am Coll Cardiol. 1996 Mar 1;27(3):517-27
2681479 - J Lab Clin Med. 1989 Nov;114(5):473-501
16735675 - Circulation. 2006 Jun 6;113(22):2623-9
20937919 - Arch Intern Med. 2010 Oct 11;170(18):1622-31
18412997 - Proc Nutr Soc. 2008 May;67(2):232-7
24585266 - Eur Heart J. 2014 Nov 1;35(41):2864-72
5792556 - Am J Pathol. 1969 Jul;56(1):111-28
16531613 - N Engl J Med. 2006 Apr 13;354(15):1567-77
18227386 - Circulation. 2008 Feb 12;117(6):823-31
2407253 - Atherosclerosis. 1990 Feb;81(1):51-60
2011158 - N Engl J Med. 1991 Apr 25;324(17):1149-55
1987384 - J Vasc Surg. 1991 Jan;13(1):128-36
26865327 - Sci Rep. 2016 Feb 11;6:17966
11398138 - Metabolism. 2001 Jun;50(6):640-5
References_xml – volume: 313
  start-page: 1325
  year: 2015
  ident: bib35
  article-title: Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China
  publication-title: JAMA
– volume: 374
  start-page: 861
  year: 2016
  end-page: 871
  ident: bib1
  article-title: Clinical practice. Peripheral artery disease
  publication-title: N. Engl. J. Med.
– volume: 113
  start-page: 2623
  year: 2006
  end-page: 2629
  ident: bib24
  article-title: Risk factors for progression of peripheral arterial disease in large and small vessels
  publication-title: Circulation
– volume: 467
  start-page: 14
  year: 2014
  end-page: 21
  ident: bib31
  article-title: Using S-adenosyl-L-homocysteine capture compounds to characterize S-adenosyl-L-methionine and S-adenosyl-L-homocysteine binding proteins
  publication-title: Anal. Biochem.
– volume: 11
  start-page: 217
  year: 1997
  end-page: 223
  ident: bib18
  article-title: Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease
  publication-title: Ann. Vasc. Surg.
– volume: 25
  start-page: 282
  year: 1996
  end-page: 290
  ident: bib3
  article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease
  publication-title: Int. J. Epidemiol.
– volume: 338
  start-page: 1042
  year: 1998
  end-page: 1050
  ident: bib9
  article-title: Homocysteine and atherothrombosis
  publication-title: N. Engl. J. Med.
– volume: 38
  start-page: 316
  year: 2009
  end-page: 322
  ident: bib17
  article-title: Homocysteine and peripheral arterial disease: systematic review and meta-analysis
  publication-title: Eur. J. Vasc. Endovasc. Surg.
– volume: 56
  start-page: 111
  year: 1969
  end-page: 128
  ident: bib6
  article-title: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis
  publication-title: Am. J. Pathol.
– volume: 59
  start-page: 1087
  year: 2006
  end-page: 1091
  ident: bib22
  article-title: Review: a gentle introduction to imputation of missing values
  publication-title: J. Clin. Epidemiol.
– volume: 81
  start-page: 51
  year: 1990
  end-page: 60
  ident: bib15
  article-title: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
  publication-title: Atherosclerosis
– volume: 117
  start-page: 823
  year: 2008
  end-page: 831
  ident: bib26
  article-title: Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk
  publication-title: Circulation
– volume: 354
  start-page: 1567
  year: 2006
  end-page: 1577
  ident: bib36
  article-title: Homocysteine lowering with folic acid and B vitamins in vascular disease
  publication-title: N. Engl. J. Med.
– volume: 96
  start-page: 239
  year: 1994
  end-page: 246
  ident: bib11
  article-title: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
  publication-title: Am. J. Med.
– volume: 324
  start-page: 1149
  year: 1991
  end-page: 1155
  ident: bib14
  article-title: Hyperhomocysteinemia: an independent risk factor for vascular disease
  publication-title: N. Engl. J. Med.
– volume: 101
  start-page: 875
  year: 2012
  end-page: 883
  ident: bib21
  article-title: Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography
  publication-title: Clin. Res. Cardiol.
– volume: 50
  start-page: 640
  year: 2001
  end-page: 645
  ident: bib28
  article-title: Factors explaining the difference of total homocysteine between men and women in the European Investigation into Cancer and Nutrition Potsdam study
  publication-title: Metabolism
– volume: 114
  start-page: 473
  year: 1989
  end-page: 501
  ident: bib7
  article-title: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy
  publication-title: J. Lab. Clin. Med.
– volume: 170
  start-page: 1622
  year: 2010
  end-page: 1631
  ident: bib37
  article-title: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals
  publication-title: Arch. Intern Med.
– volume: 235
  start-page: 94
  year: 2014
  end-page: 101
  ident: bib27
  article-title: Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease
  publication-title: Atherosclerosis
– volume: 7
  start-page: 391
  year: 1993
  end-page: 396
  ident: bib16
  article-title: Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50–effect of smoking and extent of disease
  publication-title: Eur. J. Vasc. Surg.
– volume: 382
  start-page: 1329
  year: 2013
  end-page: 1340
  ident: bib2
  article-title: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
  publication-title: Lancet
– volume: 35
  start-page: 2864
  year: 2014
  end-page: 2872
  ident: bib5
  article-title: Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
  publication-title: Eur. Heart J.
– volume: 285
  start-page: 2481
  year: 2001
  end-page: 2485
  ident: bib23
  article-title: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
  publication-title: JAMA
– volume: 49
  start-page: 711
  year: 2009
  end-page: 718
  ident: bib34
  article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis
  publication-title: J. Vasc. Surg.
– volume: 2
  start-page: 386
  year: 1996
  end-page: 389
  ident: bib8
  article-title: Homocysteine and vascular disease
  publication-title: Nat. Med.
– volume: 67
  start-page: 232
  year: 2008
  end-page: 237
  ident: bib33
  article-title: Homocysteine, B-vitamins and CVD
  publication-title: Proc. Nutr. Soc.
– volume: 12
  start-page: 517
  year: 2002
  end-page: 528
  ident: bib30
  article-title: Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation
  publication-title: Pharmacogenetics
– volume: 274
  start-page: 1049
  year: 1995
  end-page: 1057
  ident: bib13
  article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
  publication-title: JAMA
– volume: 295
  start-page: 180
  year: 2006
  end-page: 189
  ident: bib4
  article-title: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
  publication-title: JAMA
– volume: 8
  start-page: 211
  year: 2015
  end-page: 219
  ident: bib32
  article-title: Homocysteine and the pathogenesis of atherosclerosis
  publication-title: Expert Rev. Clin. Pharmacol.
– volume: 13
  start-page: 128
  year: 1991
  end-page: 136
  ident: bib25
  article-title: The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
  publication-title: J. Vasc. Surg.
– volume: 41
  start-page: S72
  year: 1993
  end-page: S77
  ident: bib10
  article-title: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
  publication-title: Kidney Int. Suppl.
– volume: 65
  start-page: 1447
  year: 2013
  end-page: 1454
  ident: bib29
  article-title: Mass spectrometry evidence for formation of estrogen–homocysteine conjugates: estrogens can regulate homocysteine levels
  publication-title: Free Radic. Biol. Med.
– volume: 126
  start-page: 2890
  year: 2012
  end-page: 2909
  ident: bib20
  article-title: Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association
  publication-title: Circulation
– volume: 27
  start-page: 517
  year: 1996
  end-page: 527
  ident: bib12
  article-title: Homocysteine and coronary atherosclerosis
  publication-title: J. Am. Coll. Cardiol.
– volume: 6
  start-page: 17966
  year: 2016
  ident: bib19
  article-title: Hyperhomocysteinaemia is an independent risk factor of abdominal aortic aneurysm in a Chinese Han population
  publication-title: Sci. Rep.
– volume: 114
  start-page: 473
  issue: 5
  year: 1989
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib7
  article-title: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy
  publication-title: J. Lab. Clin. Med.
– volume: 354
  start-page: 1567
  issue: 15
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib36
  article-title: Homocysteine lowering with folic acid and B vitamins in vascular disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa060900
– volume: 65
  start-page: 1447
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib29
  article-title: Mass spectrometry evidence for formation of estrogen–homocysteine conjugates: estrogens can regulate homocysteine levels
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2013.07.041
– volume: 382
  start-page: 1329
  issue: 9901
  year: 2013
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib2
  article-title: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61249-0
– volume: 27
  start-page: 517
  issue: 3
  year: 1996
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib12
  article-title: Homocysteine and coronary atherosclerosis
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/0735-1097(95)00508-0
– volume: 41
  start-page: S72
  year: 1993
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib10
  article-title: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
  publication-title: Kidney Int. Suppl.
– volume: 67
  start-page: 232
  issue: 2
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib33
  article-title: Homocysteine, B-vitamins and CVD
  publication-title: Proc. Nutr. Soc.
  doi: 10.1017/S0029665108007076
– volume: 7
  start-page: 391
  issue: 4
  year: 1993
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib16
  article-title: Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50–effect of smoking and extent of disease
  publication-title: Eur. J. Vasc. Surg.
  doi: 10.1016/S0950-821X(05)80255-5
– volume: 313
  start-page: 1325
  issue: 13
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib35
  article-title: Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China
  publication-title: JAMA
  doi: 10.1001/jama.2015.2274
– volume: 59
  start-page: 1087
  issue: 10
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib22
  article-title: Review: a gentle introduction to imputation of missing values
  publication-title: J. Clin. Epidemiol.
  doi: 10.1016/j.jclinepi.2006.01.014
– volume: 467
  start-page: 14
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib31
  article-title: Using S-adenosyl-L-homocysteine capture compounds to characterize S-adenosyl-L-methionine and S-adenosyl-L-homocysteine binding proteins
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2014.08.013
– volume: 374
  start-page: 861
  issue: 9
  year: 2016
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib1
  article-title: Clinical practice. Peripheral artery disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMcp1507631
– volume: 50
  start-page: 640
  issue: 6
  year: 2001
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib28
  article-title: Factors explaining the difference of total homocysteine between men and women in the European Investigation into Cancer and Nutrition Potsdam study
  publication-title: Metabolism
  doi: 10.1053/meta.2001.23286
– volume: 101
  start-page: 875
  issue: 11
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib21
  article-title: Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography
  publication-title: Clin. Res. Cardiol.
  doi: 10.1007/s00392-012-0471-z
– volume: 56
  start-page: 111
  issue: 1
  year: 1969
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib6
  article-title: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis
  publication-title: Am. J. Pathol.
– volume: 170
  start-page: 1622
  issue: 18
  year: 2010
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib37
  article-title: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals
  publication-title: Arch. Intern Med.
  doi: 10.1001/archinternmed.2010.348
– volume: 49
  start-page: 711
  issue: 3
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib34
  article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis
  publication-title: J. Vasc. Surg.
  doi: 10.1016/j.jvs.2008.10.004
– volume: 285
  start-page: 2481
  issue: 19
  year: 2001
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib23
  article-title: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
  publication-title: JAMA
  doi: 10.1001/jama.285.19.2481
– volume: 235
  start-page: 94
  issue: 1
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib27
  article-title: Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2014.04.010
– volume: 12
  start-page: 517
  issue: 7
  year: 2002
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib30
  article-title: Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation
  publication-title: Pharmacogenetics
  doi: 10.1097/00008571-200210000-00003
– volume: 35
  start-page: 2864
  issue: 41
  year: 2014
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib5
  article-title: Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehu080
– volume: 81
  start-page: 51
  issue: 1
  year: 1990
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib15
  article-title: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
  publication-title: Atherosclerosis
  doi: 10.1016/0021-9150(90)90058-Q
– volume: 126
  start-page: 2890
  issue: 24
  year: 2012
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib20
  article-title: Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e318276fbcb
– volume: 38
  start-page: 316
  issue: 3
  year: 2009
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib17
  article-title: Homocysteine and peripheral arterial disease: systematic review and meta-analysis
  publication-title: Eur. J. Vasc. Endovasc. Surg.
  doi: 10.1016/j.ejvs.2009.05.007
– volume: 324
  start-page: 1149
  issue: 17
  year: 1991
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib14
  article-title: Hyperhomocysteinemia: an independent risk factor for vascular disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199104253241701
– volume: 338
  start-page: 1042
  issue: 15
  year: 1998
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib9
  article-title: Homocysteine and atherothrombosis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199804093381507
– volume: 8
  start-page: 211
  issue: 2
  year: 2015
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib32
  article-title: Homocysteine and the pathogenesis of atherosclerosis
  publication-title: Expert Rev. Clin. Pharmacol.
  doi: 10.1586/17512433.2015.1010516
– volume: 113
  start-page: 2623
  issue: 22
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib24
  article-title: Risk factors for progression of peripheral arterial disease in large and small vessels
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.608679
– volume: 117
  start-page: 823
  issue: 6
  year: 2008
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib26
  article-title: Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.719369
– volume: 6
  start-page: 17966
  year: 2016
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib19
  article-title: Hyperhomocysteinaemia is an independent risk factor of abdominal aortic aneurysm in a Chinese Han population
  publication-title: Sci. Rep.
  doi: 10.1038/srep17966
– volume: 13
  start-page: 128
  issue: 1
  year: 1991
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib25
  article-title: The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
  publication-title: J. Vasc. Surg.
  doi: 10.1016/0741-5214(91)90020-U
– volume: 96
  start-page: 239
  issue: 3
  year: 1994
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib11
  article-title: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
  publication-title: Am. J. Med.
  doi: 10.1016/0002-9343(94)90149-X
– volume: 295
  start-page: 180
  issue: 2
  year: 2006
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib4
  article-title: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
  publication-title: JAMA
  doi: 10.1001/jama.295.2.180
– volume: 11
  start-page: 217
  issue: 3
  year: 1997
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib18
  article-title: Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease
  publication-title: Ann. Vasc. Surg.
  doi: 10.1007/s100169900037
– volume: 25
  start-page: 282
  issue: 2
  year: 1996
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib3
  article-title: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/25.2.282
– volume: 2
  start-page: 386
  issue: 4
  year: 1996
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib8
  article-title: Homocysteine and vascular disease
  publication-title: Nat. Med.
  doi: 10.1038/nm0496-386
– volume: 274
  start-page: 1049
  issue: 13
  year: 1995
  ident: 10.1016/j.atherosclerosis.2017.05.006_bib13
  article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
  publication-title: JAMA
  doi: 10.1001/jama.1995.03530130055028
– reference: 23928335 - Free Radic Biol Med. 2013 Dec;65:1447-54
– reference: 8606260 - J Am Coll Cardiol. 1996 Mar 1;27(3):517-27
– reference: 7563456 - JAMA. 1995 Oct 4;274(13):1049-57
– reference: 26865327 - Sci Rep. 2016 Feb 11;6:17966
– reference: 8154512 - Am J Med. 1994 Mar;96(3):239-46
– reference: 2681479 - J Lab Clin Med. 1989 Nov;114(5):473-501
– reference: 5792556 - Am J Pathol. 1969 Jul;56(1):111-28
– reference: 2011158 - N Engl J Med. 1991 Apr 25;324(17):1149-55
– reference: 8320950 - Kidney Int Suppl. 1993 Jun;41:S72-7
– reference: 11368701 - JAMA. 2001 May 16;285(19):2481-5
– reference: 25172130 - Anal Biochem. 2014 Dec 15;467:14-21
– reference: 16980149 - J Clin Epidemiol. 2006 Oct;59(10):1087-91
– reference: 23915883 - Lancet. 2013 Oct 19;382(9901):1329-40
– reference: 1987384 - J Vasc Surg. 1991 Jan;13(1):128-36
– reference: 24819748 - Atherosclerosis. 2014 Jul;235(1):94-101
– reference: 9535670 - N Engl J Med. 1998 Apr 9;338(15):1042-50
– reference: 8597939 - Nat Med. 1996 Apr;2(4):386-9
– reference: 9140594 - Ann Vasc Surg. 1997 May;11(3):217-23
– reference: 16735675 - Circulation. 2006 Jun 6;113(22):2623-9
– reference: 23159553 - Circulation. 2012 Dec 11;126(24):2890-909
– reference: 24585266 - Eur Heart J. 2014 Nov 1;35(41):2864-72
– reference: 19560951 - Eur J Vasc Endovasc Surg. 2009 Sep;38(3):316-22
– reference: 16531613 - N Engl J Med. 2006 Apr 13;354(15):1567-77
– reference: 20937919 - Arch Intern Med. 2010 Oct 11;170(18):1622-31
– reference: 18227386 - Circulation. 2008 Feb 12;117(6):823-31
– reference: 18412997 - Proc Nutr Soc. 2008 May;67(2):232-7
– reference: 25771069 - JAMA. 2015 Apr 7;313(13):1325-35
– reference: 16403930 - JAMA. 2006 Jan 11;295(2):180-9
– reference: 9119553 - Int J Epidemiol. 1996 Apr;25(2):282-90
– reference: 22584382 - Clin Res Cardiol. 2012 Nov;101(11):875-83
– reference: 19157768 - J Vasc Surg. 2009 Mar;49(3):711-8
– reference: 8359294 - Eur J Vasc Surg. 1993 Jul;7(4):391-6
– reference: 12360102 - Pharmacogenetics. 2002 Oct;12(7):517-28
– reference: 2407253 - Atherosclerosis. 1990 Feb;81(1):51-60
– reference: 11398138 - Metabolism. 2001 Jun;50(6):640-5
– reference: 26962905 - N Engl J Med. 2016 Mar 3;374(9):861-71
SSID ssj0004718
Score 2.347264
Snippet Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy and peripheral arterial...
Abstract Background and aims Hyperhomocysteineamia (HHcy) has long been suggested as a risk factor for atherosclerosis. However, the association between HHcy...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 205
SubjectTerms Aged
Ankle Brachial Index
Asian Continental Ancestry Group
Biomarkers - blood
Cardiovascular
Case-Control Studies
Case-control study
Chi-Square Distribution
China - epidemiology
Female
Homocysteine
Homocysteine - blood
Humans
Hyperhomocysteineamia
Hyperhomocysteinemia - blood
Hyperhomocysteinemia - diagnosis
Hyperhomocysteinemia - ethnology
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Peripheral arterial disease
Peripheral Arterial Disease - diagnosis
Peripheral Arterial Disease - ethnology
Prevalence
Risk Assessment
Risk Factors
Title Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0021915017301958
https://www.clinicalkey.es/playcontent/1-s2.0-S0021915017301958
https://dx.doi.org/10.1016/j.atherosclerosis.2017.05.006
https://www.ncbi.nlm.nih.gov/pubmed/28651188
https://www.proquest.com/docview/1914286828
https://pubmed.ncbi.nlm.nih.gov/PMC5557685
Volume 263
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier Freedom Collection
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: ACRLP
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: AIKHN
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: AKRWK
  dateStart: 19700101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS90wFD-IA9nLmPu800kG22NnP9KkARkTmVRFnyb4FtI0xYq2F3t99W_3nDatu-qDw5dCmo-W5OTkd8g5vwPw3SKKQKsCLVVexQFPQxtkltsgrkTlhDKc9xftxyciP-WHZ-nZCuyNsTDkVul1_6DTe23t32z72dye1zXF-OJuQzwTkZCqlAJ-if0LZfrn7b2bBynfwc0jCqj1Gvy49_HqQVbb4ZD4rIm9OxqIPCkB0tPn1GMc-tCd8p_zaf8tvPHAku0O_74OK655B2vH_ur8PbQ5WpzX5-1Va4m8uW6Mu6oNqztmGlZPyXAXjJzN2ZCGhyGiZUSF3HMPXLLe_xMFlvlrHezHDKMU3A4LOQ40n_KBfYDT_T9_9_LAZ1sIrIjEIpCmVCUvIiu45GWUWVkUnBfKJjzkTjhlTJUllSqMwroEgZIzSZXFrqSDsOTJR1ht2sZ9BmZw1kUiI4dgkMcSjbKsMFzi27BKjFQz2BnnVltPRU4ZMS716HN2oR8sjaal0WGqcWlmIKbu84GT47kdf40LqcfAU1SVGk-P5w4gnxrAdX7jdzrSXaxD_Ug4Z_B76rkk3__z8W-j7GnUAXSxYxrX3uBHFfHmCTSeZ_BpkMVpYijyGI1IrJFLUjo1IH7x5ZqmPu95xtOUjNH0y8t_fQNeU2lwnNyE1cX1jfuKYG5RbPW7dQte7R4c5Sd3Y0RQHg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7RRaK9IPpeCq0rtceIPBw7kaqqCBWFwu4JJG6W4zgiCJIVWf5_ZxIndIEDqJdIiTNOZI_H38gz3wB8M4gi0KtAT5WXocdj33iJ4cYLS1FakWrOu4P22VxkZ_zPeXy-BgdDLgyFVTrb39v0zlq7J3tuNPcWVUU5vrjaEM8EpKRpnLyAdR6jTZ7A-v7RcTa_S4-UQW-QKRoBBTbg-12YV4ezmhZ7xWtFBN5Bz-VJNZAe36oeQtH7EZX_bFGHW7DpsCXb73__NazZ-g1szNzp-VtoMnQ6by6a68YQf3NVa3tdaVa1TNesGuvhLhnFm7O-Eg9DUMuIDbmjH7hiXQgo6ixzJzsoxzSjKtwWbzLsaDGWBHsHZ4e_Tw8yzxVc8IwIxNKTukgLngdGcMmLIDEyzznPUxNxn1thU63LJCrTXKfYFiFWsjoqk9AWtBcWPHoPk7qp7UdgGkddRDKwiAd5KNEvS3LNJT71y0jLdAo_hrFVxrGRU1GMKzWEnV2qe1OjaGqUHyucmimIUXzR03I8VfDnMJFqyD1Fa6lwA3lqB_KxDmzr1n6rAtWGylcP9HMKv0bJFRV_zse_Drqn0AzQ2Y6ubXOLH02JOk-g_zyFD70ujgNDycfoR2KLXNHS8QWiGF9tqauLjmo8jskfjbf__9e_wMvsdHaiTo7mx5_gFbX0cZQ7MFne3NpdxHbL_LNbu38BlKBSyQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperhomocysteinaemia+is+an+independent+risk+factor+for+peripheral+arterial+disease+in+a+Chinese+Han+population&rft.jtitle=Atherosclerosis&rft.au=Rong%2C+Dan&rft.au=Liu%2C+Jie&rft.au=Jia%2C+Xin&rft.au=AL-Nafisee%2C+Daniah&rft.date=2017-08-01&rft.issn=0021-9150&rft.eissn=1879-1484&rft.volume=263&rft.spage=205&rft.epage=210&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2017.05.006&rft_id=info%3Apmid%2F28651188&rft.externalDocID=PMC5557685
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon